Evidence map›Paper›PMID 35906026›Full record

ArticleRMD open2022

EULAR points to consider for including the perspective of young patients with inflammatory arthritis into patient-reported outcomes measures.

Paul Studenic, Tanja A Stamm, Erika Mosor, Ilaria Bini, Nele Caeyers, Laure Gossec, Marios Kouloumas, Elena Nikiphorou, Wendy Olsder, Ivan Padjen and 4 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in RMD open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Paul StudenicDepartment of Internal Medicine 3, Division of Rheumatology, Medical University of Vienna, Wien, Austria paul.studenic@meduniwien.ac.at.ORCID 0000-0002-8895-6941
Tanja A StammLudwig Boltzmann Institut für Arthritis und Rehabilitation, Wien, Austria.ORCID 0000-0003-3073-7284
Erika MosorLudwig Boltzmann Institut für Arthritis und Rehabilitation, Wien, Austria.ORCID 0000-0003-4293-0647
Ilaria BiniAnmar Young, Rome, Italy.
Nele CaeyersEULAR PARE, Zürich, Switzerland.
Laure GossecINSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, INSERM, Sorbonne Universite, Paris, France.ORCID 0000-0002-4528-310X
Marios KouloumasCyprus League Against Rheumatism, Aglantzia, Cyprus.
Elena NikiphorouCentre for Rheumatic Diseases, King's College London, London, UK.ORCID 0000-0001-6847-3726
Wendy OlsderEULAR Young PARE, Zürich, Switzerland.
Ivan PadjenDepartment of Internal Medicine, Division of Clinical Immunology and Rheumatology, University Hospital Centre Zagreb, Zagreb, Croatia.
Sofia RamiroDepartment of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0002-8899-9087
Simon StonesEULAR PARE, Zürich, Switzerland.
Tanita-Christina WilhelmerEULAR Young PARE, Zürich, Switzerland.
Alessia AlunnoDepartment of Life, Health and Environmental Sciences, University of L'Aquila, L'Aguila, Italy.ORCID 0000-0003-1105-5640

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antirheumatic AgentsArthritisHumansPatient Reported Outcome MeasuresAntirheumatic Agentsarthritisoutcome assessment, health carepatient reported outcome measures

Identifiers

PMID35906026
PMCPMC9345076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.